Vulvar Cancer Global Clinical Trials Review, H1, 2012

Vulvar Cancer Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H1, 2012" provides data on the Vulvar Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vulvar Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vulvar Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Contents

Introduction
Vulvar Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Vulvar Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Vulvar Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
UMC Utrecht
Clinical Trial Overview of UMC Utrecht
Precision Therapeutics, Inc.
Clinical Trial Overview of Precision Therapeutics, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Gynecologic Oncology Group
Clinical Trial Overview of Gynecologic Oncology Group
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Leiden University Medical Center
Clinical Trial Overview of Leiden University Medical Center
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Northwestern University
Clinical Trial Overview of Northwestern University
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
University Medical Center Groningen
Clinical Trial Overview of University Medical Center Groningen
Masonic Cancer Center
Clinical Trial Overview of Masonic Cancer Center
Brigham and Women's Hospital
Clinical Trial Overview of Brigham and Women's Hospital
The Christie NHS Foundation Trust
Clinical Trial Overview of The Christie NHS Foundation Trust
Centre Oscar Lambret
Clinical Trial Overview of Centre Oscar Lambret
Abramson Cancer Center
Clinical Trial Overview of Abramson Cancer Center
Erasmus MC
Clinical Trial Overview of Erasmus MC
Cardiff University
Clinical Trial Overview of Cardiff University
Burzynski Research Institute, Inc.
Clinical Trial Overview of Burzynski Research Institute, Inc.
University of Toronto
Clinical Trial Overview of University of Toronto
Women and Infants Hospital of Rhode Island
Clinical Trial Overview of Women and Infants Hospital of Rhode Island
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Vulvar Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Vulvar Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012*
Vulvar Cancer Therapeutics Clinical Trials, G7 Countries, 2012*
Vulvar Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Vulvar Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Vulvar Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Vulvar Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Vulvar Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Vulvar Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Vulvar Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Precision Therapeutics, Inc., 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Christie NHS Foundation Trust, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Oscar Lambret, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Women and Infants Hospital of Rhode Island, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*

LIST OF FIGURES

Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Vulvar Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Vulvar Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Vulvar Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012*
Vulvar Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Vulvar Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Vulvar Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Vulvar Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Vulvar Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top